Tilray Brands, Inc. Issues Press Release on Second Quarter Financial Results

Tilray Brands, Inc. recently released its financial results for the second quarter ending November 30, 2024. On January 10, 2025, the company issued a press release detailing these results. The report, filed as a Form 8-K with the Securities and Exchange Commission, included the press release (Exhibit 99.1).

The information disclosed in the Form 8-K and the accompanying press release is being provided for informational purposes. However, it is important to note that this information is not to be considered as filed for purposes of Section 18 of the Securities Exchange Act of 1934 or subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933.

Tilray Brands, Inc. (NASDAQ: TLRY) is listed on the NASDAQ Global Select Market with its common stock trading under the symbol TLRY.

The exhibit attached to the Form 8-K, titled Exhibit 99.1, contained a press release dated January 10, 2025, by Gencor Industries, Inc. (NYSE American: GENC). The press release dealt with a notice from NYSE Regulation about the late filing of Gencor’s Annual Report on Form 10-K for the year ended September 30, 2024.

Gencor Industries is engaged in the manufacturing of heavy machinery for highway construction materials and equipment, as well as environmental control machinery and equipment. The company intends to file its Form 10-K within the six-month period granted by the Delinquency Notification. However, there is no absolute certainty that the filing will occur within this time frame.

Cautionary statements were given regarding forward-looking statements in the press release. These statements are subject to risks and uncertainties, and actual results may vary based on various factors beyond the company’s control. Gencor advised that certain risks and uncertainties related to the business should be duly considered.

For further information on risk factors, readers are directed to the Company’s Annual Report on Form 10-K for the year ended September 30, 2023, particularly Part I, Item 1A, “Risk Factors,” and Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

The press release emphasized that any statements deemed forward-looking via expressions such as “may,” “could,” “should,” “would,” and others are meant to identify such statements. It was noted that the Company may update these forward-looking statements as required by law.

Unless otherwise specified, references in the press release pertain to Gencor Industries, Inc. and its subsidiaries.

Contact for Gencor Industries:
Eric Mellen, Chief Financial Officer
407-290-6000

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Tilray’s 8K filing here.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.